PIT for advanced or locoregionally recurrent unresectable head and neck cancer (HNC-PIT) is a recently applied local method that targets EGFR on the surface of cancer cells, and although PIT for NPSCC has been practiced in Japan since September 2020, the results remain unclear. The gene discussed is EGFR; the disease is cancer.